Noxopharm Limited 18 Share-based compensation Issue of shares There were no shares issued to directors and other key management personnel as part of compensation during the year ended 30 June 2022. Options The terms and conditions of each grant of options over ordinary shares affecting remuneration of directors and other key management personnel in this financial year or future reporting years are as follows: Grant date Vesting date and exercisable date Expiry date Exercise price Fair value per option at grant date 10 December 2018 21 November 2019 21 November 2022 $0.6200 $0.288 10 December 2018 21 November 2020 21 November 2022 $0.6200 $0.288 10 December 2018 21 November 2021 21 November 2022 $0.6200 $0.288 16 December 2019 16 December 2020 16 December 2023 $0.3200 $0.169 6 November 2020 6 November 2021 6 November 2024 $0.5500 $0.329 15 December 2020 15 December 2020 15 December 2022 $0.3150 $0.467 15 December 2020 15 December 2020 15 December 2022 $0.3150 $0.464 15 December 2020 15 December 2020 15 December 2022 $0.3150 $0.464 31 May 2021 15 December 2021 15 December 2024 $0.6810 $0.314 31 May 2021 15 December 2022 15 December 2024 $0.6810 $0.313 1 February 2022 * 1 February 2026 $0.5400 $0.310 Options granted carry no dividend or voting rights. * The performance options will vest on the achievement of any of the following: i) The Company being purchased in entirety (business sale/share sale); or ii) An AUD$10 million or greater investment in the Company; or iii) Entering into a licencing agreement with a large Pharmaceutical Company. The Directors have estimated 100% likelihood of the vesting criteria being achieved and as a result the full fair value of the options has been expensed. The number of options over ordinary shares granted to and vested by directors and other key management personnel as part of compensation during the year ended 30 June 2022 are set out below: Name Number of options granted during the year 2022 Number of options granted during the year 2021 Number of options vested during the year 2022 Number of options vested during the year 2021 Mr. Frederic Bart - 3,000,000 - 3,000,000 Mr. Boris Patkin - - 125,000 - Dr. Gisela Mautner 2,000,000 - 135,000 -
RkJQdWJsaXNoZXIy MjE2NDg3